Acorda Therapeutics logo
Acorda Therapeutics ACOR
report update icon

Quarterly report 2024-Q1
added 05-16-2026

Acorda Therapeutics Long-Term Debt | ACOR

Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.

Main characteristics:
  • Term exceeds 12 months
  • Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
  • Repaid through regular payments (interest and/or principal) over several years
Why long-term debt is needed:
  • Investment in development
    Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital.
  • Smoothing of cash flows
    A long-term payment schedule facilitates budget planning and reduces short-term financial risks.
  • Optimization of capital structure
    A combination of equity and borrowed capital can reduce the average cost of business financing.

A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.

If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.

It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.

Examples of long-term debt:
  • Mortgage loans for property purchases
  • Corporate bonds issued by a company to raise capital
  • Project financing — long-term loans for building or expanding production facilities
  • Leasing obligations for equipment or transport

Annual Long-Term Debt Acorda Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
- 167 M 151 M 138 M 193 M 319 M 309 M 299 M 290 M 288 M 493 K 1.11 M 1.9 M 3.59 M 5.63 M - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
319 M 493 K 155 M

Quarterly Long-Term Debt Acorda Therapeutics

2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1 2010-Q3 2010-Q2
2.85 M 181 M 176 M 171 M 167 M 163 M 159 M 155 M 151 M 147 M 144 M 141 M 138 M 135 M 132 M 195 M 193 M 326 M 324 M 321 M 319 M 316 M 314 M 311 M 309 M 306 M 304 M 302 M 299 M 297 M 295 M 293 M 290 M 293 M 292 M 290 M 288 M 14 K 258 K 344 K 493 K 659 K 753 K 891 K 1.11 M 1.25 M 1.54 M 1.91 M 1.9 M 2.62 M 2.99 M 3.33 M 4.37 M 4.98 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
326 M 14 K 161 M

Long-Term Debt of other stocks in the Biotechnology industry

Issuer Long-Term Debt Price % 24h Market Cap Country
Denali Therapeutics Denali Therapeutics
DNLI
5.53 M $ 18.43 1.29 % $ 3.18 B usaUSA
Pfizer Pfizer
PFE
61.6 B $ 27.4 -0.62 % $ 156 B usaUSA
Amarin Corporation plc Amarin Corporation plc
AMRN
6.08 M $ 10.56 -6.26 % $ 4.38 B irlandaIrlanda
ImmuCell Corporation ImmuCell Corporation
ICCC
7.49 M $ 11.08 -0.81 % $ 100 M usaUSA
Editas Medicine Editas Medicine
EDIT
53.6 M $ 1.63 -4.68 % $ 145 M usaUSA
Kiniksa Pharmaceuticals, Ltd. Kiniksa Pharmaceuticals, Ltd.
KNSA
6.51 M $ 93.83 0.32 % $ 6.96 B usaUSA
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
21.8 M $ 27.54 -4.24 % $ 1.6 B usaUSA
Royalty Pharma plc Royalty Pharma plc
RPRX
8.57 B $ 68.45 1.08 % $ 29.4 B usaUSA
Equillium Equillium
EQ
356 K $ 1.06 -5.36 % $ 60.7 M usaUSA
Black Diamond Therapeutics Black Diamond Therapeutics
BDTX
15.1 M $ 1.32 -5.04 % $ 75.1 M usaUSA
Abeona Therapeutics Abeona Therapeutics
ABEO
7.81 M $ 2.42 -1.17 % $ 128 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
40.6 M $ 17.1 -2.79 % $ 2.88 B usaUSA
Cleveland BioLabs, Inc. Cleveland BioLabs, Inc.
CBLI
1.5 M - -7.31 % $ 49 M usaUSA
Rhythm Pharmaceuticals Rhythm Pharmaceuticals
RYTM
101 M $ 112.31 -3.84 % $ 7.3 B usaUSA
ADC Therapeutics SA ADC Therapeutics SA
ADCT
1.03 M $ 1.29 -2.28 % $ 164 M schweizSchweiz
Harmony Biosciences Holdings Harmony Biosciences Holdings
HRMY
144 M $ 32.58 -1.21 % $ 1.87 B usaUSA
Ardelyx Ardelyx
ARDX
203 M $ 2.99 -2.25 % $ 721 M usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
48.2 M $ 0.39 -8.41 % $ 100 M usaUSA
Alector Alector
ALEC
9.32 M $ 2.34 1.52 % $ 241 M usaUSA
ALX Oncology Holdings ALX Oncology Holdings
ALXO
4.53 M $ 1.06 3.43 % $ 56.9 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
2.57 B $ 21.12 -1.26 % $ 6.62 B usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
806 K $ 4.03 -1.11 % $ 772 M canadaCanada
Agenus Agenus
AGEN
30.5 M $ 5.97 -2.85 % $ 178 M usaUSA
PolyPid Ltd. PolyPid Ltd.
PYPD
647 K $ 6.1 -6.87 % $ 99.7 M israelIsrael
AbCellera Biologics AbCellera Biologics
ABCL
137 M $ 9.63 -8.02 % $ 2.88 B canadaCanada
Artelo Biosciences Artelo Biosciences
ARTL
29 K $ 1.35 -6.9 % $ 255 K usaUSA
Immatics N.V. Immatics N.V.
IMTX
12.9 M $ 5.76 -3.19 % $ 705 M germanyGermany
Aptevo Therapeutics Aptevo Therapeutics
APVO
3.76 M $ 0.4 -2.61 % $ 126 K usaUSA
Aligos Therapeutics Aligos Therapeutics
ALGS
122 K $ 1.22 -2.4 % $ 12.1 M usaUSA
Aclaris Therapeutics Aclaris Therapeutics
ACRS
1.56 M $ 3.44 -1.86 % $ 422 M usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
127 M $ 27.46 -2.1 % $ 4.17 B usaUSA
Cellectar Biosciences Cellectar Biosciences
CLRB
309 K $ 0.83 -8.27 % $ 2.16 M usaUSA
Biofrontera AG Biofrontera AG
BFRA
20.1 M - -8.24 % $ 105 M germanyGermany
SIGA Technologies SIGA Technologies
SIGA
200 K $ 2.4 -9.06 % $ 172 M usaUSA
Catabasis Pharmaceuticals, Inc. Catabasis Pharmaceuticals, Inc.
CATB
2.48 M - -6.97 % $ 657 M usaUSA
Capricor Therapeutics Capricor Therapeutics
CAPR
14.3 M $ 7.56 0.4 % $ 351 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
620 M $ 28.3 0.68 % $ 1.32 B usaUSA
China Biologic Products Holdings, Inc. China Biologic Products Holdings, Inc.
CBPO
40 M - 1.68 % $ 4.65 B chinaChina
Sol-Gel Technologies Ltd. Sol-Gel Technologies Ltd.
SLGL
496 K $ 55.64 2.88 % $ 155 M israelIsrael
Syndax Pharmaceuticals Syndax Pharmaceuticals
SNDX
1.58 M $ 8.71 -4.16 % $ 755 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
45 M $ 3.47 -6.48 % $ 371 M usaUSA
Pliant Therapeutics Pliant Therapeutics
PLRX
30.2 M $ 0.59 -4.42 % $ 36.2 M usaUSA
Jaguar Health Jaguar Health
JAGX
892 K $ 0.24 -27.06 % $ 560 K usaUSA
Arvinas Arvinas
ARVN
400 K $ 6.41 -4.9 % $ 454 M usaUSA
Cerus Corporation Cerus Corporation
CERS
10.2 M $ 1.86 -2.37 % $ 355 M usaUSA
Beam Therapeutics Beam Therapeutics
BEAM
140 M $ 20.87 -0.36 % $ 2.06 B usaUSA
Inhibrx Inhibrx
INBX
1.11 M $ 68.81 -7.43 % $ 3.24 B usaUSA
Scholar Rock Holding Corporation Scholar Rock Holding Corporation
SRRK
99.7 M $ 48.09 -4.54 % $ 5.52 B usaUSA